Home › Funds › Armstrong, Fleming & Moore, Inc › JNJ

Armstrong, Fleming & Moore, Inc position in JNJ

JOHNSON & JOHNSON · Health Care

Armstrong, Fleming & Moore, Inc reported holding 13,815 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$3.7M, representing 1.21% of its reported portfolio and ranking #11 among its reported holdings. Armstrong, Fleming & Moore, Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.81K sh
Reported value held$3.66M
Portfolio Weight1.21%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Armstrong, Fleming & Moore, Inc's JNJ position evolved

Armstrong, Fleming & Moore, Inc first disclosed a stake in JNJ in Q3 2023 at 14,711 shares (US$2.3M). The position peaked in Q3 2026 at 13,815 shares, worth US$3.7M. Across 13 filings, Armstrong, Fleming & Moore, Inc increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 13,815 shares valued at US$3.7M — a reduction of -98 shares quarter over quarter.. Notable position changes include a 68% trim in Q1 2025 (shares fell 6% over the following quarter), a 222% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.71K $2.29M New
Q4 2023 14.64K $2.30M Hold
Q1 2024 13.35K $2.11M Reduce
Q2 2024 13.33K $1.95M Hold
Q3 2024 12.47K $2.02M Reduce
Q4 2024 12.28K $1.78M Reduce
Q1 2025 3.92K $649.19K Reduce
Q2 2025 12.59K $1.92M Add
Q3 2025 12.57K $2.33M Hold
Q4 2025 12.58K $2.60M Hold
Q1 2026 13.95K $3.41M Add
Q2 2026 13.91K $3.53M Hold
Q3 2026 13.81K $3.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Armstrong, Fleming & Moore, Inc held JNJ?

Armstrong, Fleming & Moore, Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Armstrong, Fleming & Moore, Inc's current position in JNJ?

As of Q3 2026, Armstrong, Fleming & Moore, Inc holds 13.81K shares of JNJ (JOHNSON & JOHNSON), valued at $3.66M, representing 1.21% of its reported portfolio and ranking #11.

Has Armstrong, Fleming & Moore, Inc been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Armstrong, Fleming & Moore, Inc reduced its position in JNJ. The position peaked in Q3 2026 at 13.81K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.